OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
David W. Crabb, Gene Y. Im, Gyöngyi Szabó, et al.
Hepatology (2019) Vol. 71, Iss. 1, pp. 306-333
Open Access | Times Cited: 674
David W. Crabb, Gene Y. Im, Gyöngyi Szabó, et al.
Hepatology (2019) Vol. 71, Iss. 1, pp. 306-333
Open Access | Times Cited: 674
Showing 1-25 of 674 citing articles:
Liver cirrhosis
Pere Ginès, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 932
Pere Ginès, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 932
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra, Arka De, Abhijit Chowdhury
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 16-16
Open Access | Times Cited: 412
Souveek Mitra, Arka De, Abhijit Chowdhury
Translational Gastroenterology and Hepatology (2020) Vol. 5, pp. 16-16
Open Access | Times Cited: 412
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 267
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 267
Diagnosis and Treatment of Alcohol-Associated Liver Disease
Ashwani K. Singal, Philippe Mathurin
JAMA (2021) Vol. 326, Iss. 2, pp. 165-165
Closed Access | Times Cited: 236
Ashwani K. Singal, Philippe Mathurin
JAMA (2021) Vol. 326, Iss. 2, pp. 165-165
Closed Access | Times Cited: 236
Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol‐Associated Liver Disease
Ben L. Da, Gene Y. Im, Thomas D. Schiano
Hepatology (2020) Vol. 72, Iss. 3, pp. 1102-1108
Closed Access | Times Cited: 227
Ben L. Da, Gene Y. Im, Thomas D. Schiano
Hepatology (2020) Vol. 72, Iss. 3, pp. 1102-1108
Closed Access | Times Cited: 227
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, et al.
Hepatology (2020) Vol. 72, Iss. 3, pp. 845-856
Open Access | Times Cited: 186
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, et al.
Hepatology (2020) Vol. 72, Iss. 3, pp. 845-856
Open Access | Times Cited: 186
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 143
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 143
Acute-on-Chronic Liver Failure Clinical Guidelines
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 137
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 137
Anthocyanins: Promising Natural Products with Diverse Pharmacological Activities
Jiaqi Liu, Hongbing Zhou, Li Song, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3807-3807
Open Access | Times Cited: 123
Jiaqi Liu, Hongbing Zhou, Li Song, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3807-3807
Open Access | Times Cited: 123
The multiple roles of life stress in metabolic disorders
Mika Kivimäki, Alessandro Bartolomucci, Ichiro Kawachi
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 1, pp. 10-27
Open Access | Times Cited: 115
Mika Kivimäki, Alessandro Bartolomucci, Ichiro Kawachi
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 1, pp. 10-27
Open Access | Times Cited: 115
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
The stigma of alcohol-related liver disease and its impact on healthcare
Georg Schomerus, Anya Leonhard, Jakob Manthey, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 516-524
Open Access | Times Cited: 98
Georg Schomerus, Anya Leonhard, Jakob Manthey, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 516-524
Open Access | Times Cited: 98
Liver biopsy for assessment of chronic liver diseases: a synopsis
Aqib B. Chowdhury, Kosha J. Mehta
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 273-285
Open Access | Times Cited: 82
Aqib B. Chowdhury, Kosha J. Mehta
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 273-285
Open Access | Times Cited: 82
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder
Augustin Vannier, Jessica E.S. Shay, Vladislav Fomin, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2213014-e2213014
Open Access | Times Cited: 82
Augustin Vannier, Jessica E.S. Shay, Vladislav Fomin, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2213014-e2213014
Open Access | Times Cited: 82
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review
Alessio Aghemo, О. П. Алексеева, Francesco Angelico, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1548-1560
Open Access | Times Cited: 69
Alessio Aghemo, О. П. Алексеева, Francesco Angelico, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1548-1560
Open Access | Times Cited: 69
ACG Clinical Guideline: Alcohol-Associated Liver Disease
Loretta Jophlin, Ashwani K. Singal, Ramón Bataller, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 30-54
Open Access | Times Cited: 58
Loretta Jophlin, Ashwani K. Singal, Ramón Bataller, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 30-54
Open Access | Times Cited: 58
Liver Transplantation
Michael R. Lucey, Katryn N. Furuya, David P. Foley
New England Journal of Medicine (2023) Vol. 389, Iss. 20, pp. 1888-1900
Closed Access | Times Cited: 55
Michael R. Lucey, Katryn N. Furuya, David P. Foley
New England Journal of Medicine (2023) Vol. 389, Iss. 20, pp. 1888-1900
Closed Access | Times Cited: 55
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 24
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 24
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
Brian P. Lee, Katie Witkiewitz, Jessica L. Mellinger, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 626-645
Open Access | Times Cited: 19
Brian P. Lee, Katie Witkiewitz, Jessica L. Mellinger, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 626-645
Open Access | Times Cited: 19
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis
Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 684-693
Closed Access | Times Cited: 18
Samer Gawrieh, Srinivasan Dasarathy, Wanzhu Tu, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 684-693
Closed Access | Times Cited: 18
Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly
Pojsakorn Danpanichkul, Kanokphong Suparan, Cheng Han Ng, et al.
JHEP Reports (2024) Vol. 6, Iss. 4, pp. 101020-101020
Open Access | Times Cited: 15
Pojsakorn Danpanichkul, Kanokphong Suparan, Cheng Han Ng, et al.
JHEP Reports (2024) Vol. 6, Iss. 4, pp. 101020-101020
Open Access | Times Cited: 15
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
The Lancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Clinical Trial to Assess the Safety and Tolerability of Anti‐IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease
Luis Antonio Díaz, Sheldon Morris, Shravan Dave, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 2
Luis Antonio Díaz, Sheldon Morris, Shravan Dave, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 2
